An implantable device made primarily of human demineralized bone matrix (DBM) (acid extraction of allogeneic bone resulting in loss of most of the mineralized component but retention of proteins) intended to fill bony voids or gaps caused by trauma or surgery,
| Company | Devices | Share |
|---|---|---|
| Xtant Medical Holdings, Inc. | 206 | 24% |
| Hans Biomed Corp. | 125 | 15% |
| Rti Surgical, Inc. | 95 | 11% |
| Medtronic Sofamor Danek, Inc. | 79 | 9% |
| Isotis Orthobiologics, Inc. | 71 | 8% |
| Musculoskeletal Transplant Foundation, Inc. | 36 | 4% |
| Allosource | 24 | 3% |
| Lifenet Health | 22 | 3% |
| Stryker Corporation | 21 | 2% |
| Wright Medical Technology, Inc. | 20 | 2% |
| Seaspine Orthopedics Corporation | 20 | 2% |
| Nuvasive, Inc. | 19 | 2% |
Company = labeler of record on GUDID. 25 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| MQV | Filler, Bone Void, Calcium Compound | 480 |
| MBP | Filler, Bone Void, Osteoinduction (W/O Human Growth Factor) | 449 |
| MQV | FILLER, BONE VOID, CALCIUM COMPOUND | 414 |
| MBP | Filler, bone void, osteoinduction (w/o human growth factor) | 260 |
| NUN | Bone Grafting Material, Human Source | 71 |
| GXP | Methyl Methacrylate For Cranioplasty | 58 |
Use these as the dimensions to specify in a tender line.
860 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Human-derived demineralized bone matrix implant", from 25 companies. The largest labeler is Xtant Medical Holdings, Inc. with 24% of records.
MQV (Filler, Bone Void, Calcium Compound), MBP (Filler, Bone Void, Osteoinduction (W/O Human Growth Factor)), MQV (FILLER, BONE VOID, CALCIUM COMPOUND), MBP (Filler, bone void, osteoinduction (w/o human growth factor))
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add human-derived demineralized bone matrix implant to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.